Apr 26, 2018 · Acclarent, Inc, part of the Johnson & Johnson Medical Devices Companies* that develops minimally-invasive Ear, Nose, & Throat (ENT) technologies, announced the US commercial launch of TruDi, a real-time, three-dimensional (3D) navigation system for ENT procedures performed in the operating room and surgeon’s office.
31400609 7453. 31400617 5637. 31400898 2295. 31400005 7453. 31400021 5637. 31400450 2540. 31400393 2315. 31400518 2046. 31400641 1522. 31400476 1522. 31401003 4339 ...
12. Acclarent is a medical device company that sells balloon sinuplasty devices. ... system/relieva-spinplus-balloon-sinuplasty-system). I (available. at.
Jun 06, 2017 · The Relieva SpinPlus Nav™ Balloon Sinuplasty System is intended to provide a means to access the sinus space within and across nasal and sinus structures; dilate the sinus ostia and spaces associated with the paranasal sinus cavities for
Acclarent's new RELIEVA SpinPlus Balloon Sinuplasty System . Medicaldesignandoutsourcing.com DA: 35 PA: 50 MOZ Rank: 90. Is committed to delivering the latest technologies to ENT physicians; In 2005, Acclarent pioneered Balloon Sinus Dilation (Balloon Sinuplasty) and continues to be the market leader in this category with a variety of devices ...
Apr 01, 2015 · FDA 510(k) Decisions During April, 2015 FDA 510(k) Number: Decision Date: Device Name: Applicant: Contact: K142745: 04/01/2015
for patent protection for) Acclarent’s Relieva Spin® and SpinPlus® devices (the “Relieva Devices”). 9. Venue is proper under 28 U.S.C. §§ 1391 and 1400 because Acclarent has committed, and continues to commit, acts of infringement in this District and is subject to personal jurisdiction within this state.
catheter irrigation relieva spin relieva vortex 2 l16 mm od6 mm maxillary m-110 tip balloon sinuplasty CATHETER IRRIGATION RELIEVA VORTEX 2 SINUS 1 HANDED CONTROL DURABLE PRECISE SMOOTH EXCHANGE CATHETER JB2 4F 100 CM LENGTH 451424H0
relieva spinplus nav rsp0516mfsn gudid 20705031241005 relieva spinplus nav balloon sinuplasty system, 5x16mm, 3 guide kit acclarent, inc. fda.report